Betagan

Betagan

Generic: Levobunolol HCI ophthalmic solution, USP 0.25%, 0.5%

 

 

Betagan
DOSAGE 1-2 gtts QD or BID
GENERIC Levobunolol HCI ophthalmic solution, USP 0.25%, 0.5%
SIZE 5mL, 10mL, 15mL
INDICATIONS Reduces intraocular pressure (IOP)
MECHANISM OF ACTION Non-selective beta adrenergic receptor blocker
MICROBIOLOGY The predominant mechanism of ocular hypotensive action of topical beta-adrenergic blocking agents is likely due to a reduction in aqueous humor production
CONTRAINDICATIONS & WARNINGS Patients with bronchial asthma, or with a history of bronchial asthma, or severe chronic obstructive pulmonary disease, sinus bradycardia; second and third degree atrioventricular block; overt cardiac failure, cardiogenic shock; or hypersensitivity to any component of these products.
PEDIATRIC USE Safety and effectiveness in pediatric patients have not been established.
PREGNANCY Pregnancy category C | There are no adequate and well-controlled studies in pregnant women. BETAGAN® ophthalmic solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus
NOTE